Increasing Efficacy and Minimizing Dosing Burden
Many injectable and oral solid dosage forms can be restricted to very low drug concentrations per dose due to the nature of the compound. As a result, there is a risk of reduced efficacy as well increased frequency of dosing. This can have a critical effect on patient compliance and consequently clinical outcomes.
Lucideon’s high-loading platform, developed for the delivery of injectable and oral delivery routes, helps you to improve your product size, dosing frequency and stability.
- Has high loading capacity
- Reduces viscosity
- Increases stability
- Reduces dosing frequency
- Limits aggregation.
Examples of applications:
- High concentration/low volume biologics
- Ocular injections
- Low volume formulations - liquid and solid
- Intramuscular and subcutaneous formulations
- Poorly soluble compounds.
We work with you to find the best options for your clinical needs. Click here to learn more about our supporting services, including formulation development.
Contact us today to learn about our increased loading platform.